Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham D Hogg

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal for Immunotherapy of Cancer|January 20, 2021
Rethinking immune checkpoint blockade: 'Beyond the T cell'Xiuting Liu, Graham D Hogg, David G DeNardo
Applied and Environmental Microbiology|December 12, 2023
Seasonal trends in lysogeny in an Appalachian oak-hickory forest soilMelaina L Jacoby, Graham D Hogg, Madeleine R Assaad, et al.
Frontiers in Immunology|February 17, 2022
Phenotypic and Functional Plasticity of CXCR6<sup>+</sup> Peripheral Blood NK CellsLaura S Angelo, Graham D Hogg, Shawn Abeynaike, et al.
Frontiers in Immunology|December 26, 2022
Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancerHui Peng, Lijin Li, Chong Zuo, et al.
Oncoimmunology|March 20, 2024
Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinomaVikram S Pothuri, Graham D Hogg, Leah Conant, et al.
Science Translational Medicine|June 7, 2023
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancerBrett H Herzog, John M Baer, Nicholas Borcherding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic CancerHui Peng, C Alston James, Darren R Cullinan, et al.
Science Translational Medicine|July 5, 2019
Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapiesRoheena Z Panni, John M Herndon, Chong Zuo, et al.
Cancer Immunology Research|May 25, 2023
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic CancerC Alston James, John M Baer, Chong Zou, et al.
Cancer Cell|March 19, 2020
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic CancerSamarth Hegde, Varintra E Krisnawan, Brett H Herzog, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal for Immunotherapy of Cancer|January 20, 2021
Rethinking immune checkpoint blockade: 'Beyond the T cell'Xiuting Liu, Graham D Hogg, David G DeNardo
Applied and Environmental Microbiology|December 12, 2023
Seasonal trends in lysogeny in an Appalachian oak-hickory forest soilMelaina L Jacoby, Graham D Hogg, Madeleine R Assaad, et al.
Frontiers in Immunology|February 17, 2022
Phenotypic and Functional Plasticity of CXCR6<sup>+</sup> Peripheral Blood NK CellsLaura S Angelo, Graham D Hogg, Shawn Abeynaike, et al.
Frontiers in Immunology|December 26, 2022
Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancerHui Peng, Lijin Li, Chong Zuo, et al.
Oncoimmunology|March 20, 2024
Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinomaVikram S Pothuri, Graham D Hogg, Leah Conant, et al.
Science Translational Medicine|June 7, 2023
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancerBrett H Herzog, John M Baer, Nicholas Borcherding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic CancerHui Peng, C Alston James, Darren R Cullinan, et al.
Science Translational Medicine|July 5, 2019
Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapiesRoheena Z Panni, John M Herndon, Chong Zuo, et al.
Cancer Immunology Research|May 25, 2023
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic CancerC Alston James, John M Baer, Chong Zou, et al.
Cancer Cell|March 19, 2020
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic CancerSamarth Hegde, Varintra E Krisnawan, Brett H Herzog, et al.
Pageof 2